Background: Reduction mammaplasty is an established and effective technique to treat
symptomatic macromastia. Variable rates of complications have been reported, and there is …

Background Gigantomastia is a debilitating condition characterised by an excessive breast
tissue growth impacting patients' quality of life. Surgically treatment options include the …

Background Tranexamic acid (TXA) has gained increasing recognition as a valuable
pharmacologic agent within plastic surgery. Objectives The aim of this study was to …

Background Reduction mammoplasty in patients with gigantic breast hypertrophy runs a
high risk of complication. Traditionally, inferior pedicle reductions or free nipple grafting …

Background: The use of systemic prophylactic antibiotics to reduce surgical-site infection in
aesthetic breast surgery remains controversial. The aim of this review is to weigh the …

Abstract Introduction BREAST-Q™ is a patient-reported outcomes survey instrument with a
specific module that evaluates breast reduction surgery. It allows assessment of patient's …

A multidisciplinary work group involving stakeholders from various backgrounds and
societies convened to revise the guideline for reduction mammaplasty. The goal was to …

Background: Reduction mammaplasty provides symptomatic relief to patients with
macromastia. Insurance companies act as gatekeepers of health care by determining the …

Background: The central mound technique offers a relatively less common approach for
breast reduction. This study evaluated the expected safety and efficacy outcomes using this …

Background: Reduction mammaplasty is the standard of care for symptomatic macromastia.
The process of requesting insurance coverage for reduction mammaplasty is cumbersome …